Tuesday, 10 Mar 2015 5:30 PM
“What Global Companies seek in Israeli Bio-Entrepreneurship”
Tuesday, March 10th, 2015
with guest speakers:
• Jonathan Goldstein – Boston Scientific
• Rafael Torgovicky, Medical & Regulatory Director, Eli Lilly
• Jordan Feder, Associate, GE Ventures (Israel)
• Liana Naim, Earthbound LLC (EB)
JBNF-Biomed has invited 4 global companies to send their investment managers or technical scouts to take part in a panel where each company will present what they are looking for in Israeli life science technology and at what stage as well as how to work with them. This event is important for every bio entrepreneur and professional to be better acquainted to an important sector of the investment scene. It is also an opportunity to show these global life science companies that Jerusalem is rapidly becoming the focus of Israeli life science startups.
The Life Science sector in Israel is one of the fastest growing industries, with an average of 17% annual growth over the last decade and sales of $ 6 billion in 2015. Israel’s life science exports are set to double in the next five years, fueled by the R&D activities. There are over 1,000 life science companies in Israel with over 110 of them based in Jerusalem. A major contribution to investment in Israeli life science are global companies, with over 15 global companies with R&D centers based in Israel with technology scouts, company acquisition and VC funding scorching the Israeli science. Over the last decade, over 15 major acquisitions took place in Jerusalem with Oridion Medical being acquired by Covidien and Omrix by Johnson and Johnson.
Sponsored by the JCT – Lev Academic Center, Bio-Jerusalem, and the Jerusalem Business Networking Forum – Biomed Division
The presentations will all be given in English.
RVSP to reserve your place. There will be a 20 NIS entrance fee to the event.
About our speakers:
Jonathan Goldstein, Boston Scientific
Jonathan Goldstein has been working for the Corporate Research Division of Boston Scientific since mid 2012, covering Israeli technology and projects for the Company, particularly for projects at the interface of R&D and Business Development. The work performed for the Division involves interaction across the Divisional/Corporate boundaries, in order to improve access to technologies, assessment procedures, as well as a more strategic interplay towards innovation throughout the organization.
Jonathan started out as a strategy consultant for Metapraxis Ltd. in London in the early 90s, working with blue-chip companies such as Unilever, Kleinwort Benson and S.G. Warburg. Since moving to Israel, he has focused on the biomedical field. He worked initially at Jerusalem Global, one of Israel’s key hitech investment banks, and then as a Business Development Executive in some of Israel’s most innovative biomedical companies, as well as being on the Advisory Board of the award-winning Meytav Technology Incubator. More recently, Jonathan has acted as adviser to Zimmer Orthopedics, and to Itochu Corporation regarding European and Israeli medical device investment opportunities.Jonathan is the Israel Editor of Medical Device Daily of the US (a Reuters Publication). In addition, he is the Founder of a biomedical company focusing on a novel approach to personalized cancer treatments. He holds a BSc. in Chemistry & Biochemistry from Imperial College, London, and an MBA from the University of London.
Rafael Torgovicky, MD
Medical & Regulatory Director, Eli Lilly
Rafael Torgovicky is an experienced pharmaceutical physician and a specialist in Pharmaceutical Medicine, with over 10 years of clinical practice and working for the pharma industry in several roles in the area of clinical research (early+late development), clinical pharmacology, regulatory affairs, in-licensing, and medical affairs. This is supported by extensive academic background from Tel Aviv University (M.D, M.H.A) and Basel university (“University Professional in Pharmaceutical Medicine”).
Jordan Feder, Associate, GE Ventures (Israel)
GE Ventures combines capital, technical and commercial expertise, infrastructure, and the GE global network of businesses and partners to scale great ideas while driving growth for our start-up partners and GE. GE Ventures goal is to become the global partner of choice to accelerate growth and commercialize innovative ideas that will help drive better outcomes for our customers and society.
Jordan Feder primarily focuses on identifying innovative healthcare investments for GE Ventures, while supporting other practice areas in Israel. Prior to joining GE Ventures, Jordan was Principal at Impact First Investments, Israel’s first impact focused venture fund, where he sourced early stage digital health companies and assisted across all investment domains. Jordan holds a BA in History from the University of Wisconsin-Madison, an MA in Nonprofit Management from the Hebrew University of Jerusalem, and an MBA from the Kellogg School of Management (expected 2015).
Liana Naim – Earthbound LLC
Liana Naim has been working as technology scouter at Earthbound LLC (EB) since mid 2013.
Earthbound LLC (EB) manages a portfolio of popular brands and patented products & technologies which we license directly to major retailers creating exclusive merchandising programs. Earthbound has been introducing paradigm-shifting brands and technologies directly to mass-retailers for over a decade. The company is working with Walmart, J&J, Unilever and other leading American companies and was nominated by Unilever to establish their open innovation port here in Israel.
The goals of this port are to scout and introduce Unilever to innovation, science and technologies from Israel and to facilitate such introductions into Unilever brands and programs.
Unilever is a multinational consumer goods company. Its products include food, beverages, cleaning agents and personal care products. One of the oldest multinational companies, Unilever owns over 400 brands with several blockbusters as Axe, Dove, Omo, Lux, Rexona, Sunsilk ,Surf and others. Its products are available in around 190 countries. Unilever is a global leader in research and development through innovation and through continuous improvement of the existing products.
Liana is responsible for scouting new technologies in the fields of Personal Care & Home Care. She is Pharmaceutical Business Development consultant with over 20 years of experience in the pharmaceutical and biotechnology industry. Prior to joining the open innovation port she has been consulting several technology transfer organizations and Israeli’s startups. Prior to that she held New Project Managing positions in CTS Ltd a pharmaceutical and cosmetic company and marketing and R&D projects pharma manager in Agis-Perrigo.
Liana holds an MSc in Chemistry from the Hebrew University in Jerusalem and Marketing management studies as well as European Regulation of Medical Device and European Cosmetic Regulation Seminar